Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Google DeepMind has officially launched Gemma 3n, the latest version of its lightweight generative AI model designed ...

Logan Kilpatrick has become the public face of Google's AI offensive, and, intentionally or not, a one-man marketing machine.

Google DeepMind's Isomorphic Labs is set to begin human trials of drugs designed by artificial intelligence, marking a ...

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to ...

Google DeepMind's spinoff Isomorphic Labs is set to begin human trials of a drug desinged completely by Artificial ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

Isomorphic Labs advances towards human clinical trials for AI-designed drugs, marking a pivotal moment in pharmaceutical ...

A public feud over model originality threatens China’s collaborative AI front, with Huawei denying whistleblower claims of ...

Computers can help ensure that mathematical proofs are correct, but translating traditional maths into a machine-readable ...

The decision to end the service was ultimately made by the US Department of Defense (DoD) and affects data collected by the ...